• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Eudragit L-100 胶囊使壳聚糖具有芳香性并季铵化,用于在大鼠肝和肾的毒性氧化应激期间进行胰岛素纳米颗粒的口服递送。

Eudragit L-100 Capsules Aromatize and Quaternerize Chitosan for Insulin Nanoparticle Oral Delivery During Toxic Oxidative Stress in Rat Liver and Kidney.

机构信息

Department of Pharmaceutics, School of Pharmacy, Hamadan University of Medical Sciences, Hamadan, Iran.

Department of Pharmacology and Toxicology, School of Pharmacy, Medicinal Plants and Natural Products Research Center, Hamadan University of Medical Sciences, Hamadan, Iran.

出版信息

Pharm Nanotechnol. 2020;8(3):239-254. doi: 10.2174/2211738508666200628033442.

DOI:10.2174/2211738508666200628033442
PMID:32600243
Abstract

BACKGROUND

Insulin, like most peptides, is classified as a hydrophilic and macromolecular drug that is considered as a low permeable and unstable compound in the gastrointestinal (GI) tract. The acidic condition of the stomach can degrade insulin molecules. Moreover, the presence of proteolytic activities of some enzymes such as trypsin and chymotrypsin can hydrolyze amide-bonds between various amino-acids in the structures of peptides and proteins. However, due to its simplicity and high patient compliance, oral administration is the most preferred route of systemic drug delivery, and for the development of an oral delivery system, some obstacles in oral administration of peptides and proteins including low permeability and low stability of the proteins in GI should be overcome.

OBJECTIVE

In this study, the effects of orally insulin nanoparticles (INPs) prepared from quaternerized N-aryl derivatives of chitosan on the biochemical factors of the liver in diabetic rats were studied.

METHODS

INPs composed of methylated (amino benzyl) chitosan were prepared by the PEC method. Lyophilized INPs were filled in pre-clinical capsules, and the capsules were enteric-coated with Eudragit L100. Twenty Male Wistar rats were randomly divided into four groups: group1: normal control rats, group 2: diabetic rats, group 3: diabetic rats received capsules INPs(30 U/kg/day, orally), group 4: the diabetic rats received regular insulin (5 U/kg/day, subcutaneously). At the end of the treatment, serum, liver and kidney tissues were collected. Biochemical parameters in serum were measured using spectrophotometric methods. Also, oxidative stress was measured in plasma, liver and kidney. Histological studies were performed using H and E staining .

RESULTS

Biochemical parameters, and liver and kidney injury markers in serum of the diabetic rats that received INPs improved significantly compared with the diabetic group. INPs reduced oxidative toxic stress biomarkers in serum, liver and kidney of the diabetic treated group. Furthermore, a histopathological change was developed in the treated groups.

CONCLUSION

Capsulated INPs can prevent diabetic liver and oxidative kidney damages (similar regular insulin). Therefore oral administration of INPs appears to be safe. Lay Summary: Although oral route is the most preferred route of administration, but oral delivery of peptides and proteins is still a challenging issue. Diabetes Mellitus may lead to severe complications, which most of them are life-threatening. In this study, we are testing the toxicity of oral insulin nanoparticles in kidney and liver of rats. For this investigation, we will prepare insulin nanoparticles composed of a quaternized derivative of chitosan. The nanoparticles will be administered orally to rats and the level of oxidative stress in their liver and kidney will be determined. The data will be compared to the subcutaneous injection of insulin.

摘要

背景

胰岛素与大多数肽类一样,被归类为亲水性和大分子药物,被认为是胃肠道(GI)中渗透性差且不稳定的化合物。胃的酸性条件会降解胰岛素分子。此外,一些酶如胰蛋白酶和糜蛋白酶的蛋白水解活性的存在会水解肽和蛋白质结构中各种氨基酸之间的酰胺键。然而,由于其简单性和患者的高顺应性,口服给药是全身药物递送最优选的途径,并且为了开发口服递药系统,应该克服包括蛋白质在胃肠道中的低渗透性和低稳定性在内的口服给予肽和蛋白质的一些障碍。

目的

在这项研究中,研究了由壳聚糖的季铵化 N-芳基衍生物制备的口服胰岛素纳米粒(INPs)对糖尿病大鼠肝脏生化因子的影响。

方法

采用 PEC 法制备由甲基化(氨基苄基)壳聚糖组成的 INPs。将冻干的 INPs 填充在预临床胶囊中,并使用 Eudragit L100 对胶囊进行肠溶包衣。20 只雄性 Wistar 大鼠随机分为四组:第 1 组:正常对照组大鼠,第 2 组:糖尿病大鼠,第 3 组:糖尿病大鼠口服 INPs(30 U/kg/天),第 4 组:糖尿病大鼠皮下注射常规胰岛素(5 U/kg/天)。治疗结束时,收集血清、肝脏和肾脏组织。使用分光光度法测量血清中的生化参数。还测量了血浆、肝脏和肾脏中的氧化应激。使用 H 和 E 染色进行组织学研究。

结果

与糖尿病组相比,接受 INPs 的糖尿病大鼠血清中的生化参数以及肝和肾损伤标志物明显改善。INPs 降低了糖尿病治疗组血清、肝脏和肾脏中的氧化毒性应激生物标志物。此外,在治疗组中还发生了组织病理学变化。

结论

包封的 INPs 可预防糖尿病肝和氧化肾损伤(类似于常规胰岛素)。因此,口服 INPs 似乎是安全的。

简要说明

虽然口服途径是最优选的给药途径,但肽类和蛋白质的口服递送仍然是一个具有挑战性的问题。糖尿病可能导致严重的并发症,其中大多数是危及生命的。在这项研究中,我们正在测试口服胰岛素纳米粒在大鼠的肾脏和肝脏中的毒性。为此调查,我们将制备由壳聚糖的季铵化衍生物组成的胰岛素纳米粒。将纳米粒口服给予大鼠,并测定其肝脏和肾脏中的氧化应激水平。将数据与胰岛素的皮下注射进行比较。

相似文献

1
Eudragit L-100 Capsules Aromatize and Quaternerize Chitosan for Insulin Nanoparticle Oral Delivery During Toxic Oxidative Stress in Rat Liver and Kidney.Eudragit L-100 胶囊使壳聚糖具有芳香性并季铵化,用于在大鼠肝和肾的毒性氧化应激期间进行胰岛素纳米颗粒的口服递送。
Pharm Nanotechnol. 2020;8(3):239-254. doi: 10.2174/2211738508666200628033442.
2
Lyophilized insulin nanoparticles prepared from quaternized N-aryl derivatives of chitosan as a new strategy for oral delivery of insulin: in vitro, ex vivo and in vivo characterizations.由壳聚糖的季铵化N-芳基衍生物制备的冻干胰岛素纳米颗粒作为胰岛素口服递送的新策略:体外、离体和体内表征
Drug Dev Ind Pharm. 2014 Dec;40(12):1645-59. doi: 10.3109/03639045.2013.841187. Epub 2013 Oct 4.
3
pH-sensitive chitosan-deoxycholic acid/alginate nanoparticles for oral insulin delivery.用于口服胰岛素传递的 pH 敏感壳聚糖-脱氧胆酸/海藻酸钠纳米粒。
Pharm Dev Technol. 2021 Nov;26(9):943-952. doi: 10.1080/10837450.2021.1966036. Epub 2021 Aug 18.
4
Eudragit S100-Coated Chitosan Nanoparticles Co-loading Tat for Enhanced Oral Colon Absorption of Insulin.载有Tat的Eudragit S100包衣壳聚糖纳米粒用于增强胰岛素的口服结肠吸收
AAPS PharmSciTech. 2017 May;18(4):1277-1287. doi: 10.1208/s12249-016-0594-z. Epub 2016 Aug 1.
5
Thiolated Eudragit nanoparticles for oral insulin delivery: preparation, characterization and in vivo evaluation.巯基化壳聚糖纳米粒口服胰岛素递药系统的制备、评价及体内研究
Int J Pharm. 2012 Oct 15;436(1-2):341-50. doi: 10.1016/j.ijpharm.2012.06.054. Epub 2012 Jul 3.
6
Synthesis and characterization of a novel peptide-grafted Cs and evaluation of its nanoparticles for the oral delivery of insulin, in vitro, and in vivo study.新型肽接枝 Cs 的合成与表征及其纳米粒用于胰岛素口服给药的研究:体外与体内评价。
Int J Nanomedicine. 2018 Sep 6;13:5127-5138. doi: 10.2147/IJN.S161240. eCollection 2018.
7
Enteric-coated capsules filled with freeze-dried chitosan/poly(gamma-glutamic acid) nanoparticles for oral insulin delivery.肠溶胶囊填充冷冻干燥壳聚糖/聚(γ-谷氨酸)纳米粒用于口服胰岛素传递。
Biomaterials. 2010 Apr;31(12):3384-94. doi: 10.1016/j.biomaterials.2010.01.042. Epub 2010 Feb 10.
8
Enhancing insulin oral absorption by using mucoadhesive nanoparticles loaded with LMWP-linked insulin conjugates.利用载有 LMWP 连接胰岛素缀合物的黏膜黏附纳米粒增强胰岛素口服吸收。
J Control Release. 2016 Jul 10;233:181-90. doi: 10.1016/j.jconrel.2016.05.015. Epub 2016 May 10.
9
Effect of insulin-coated trimethyl chitosan nanoparticles on IGF-1, IGF-2, and apoptosis in the hippocampus of diabetic male rats.胰岛素包被的三甲基壳聚糖纳米颗粒对糖尿病雄性大鼠海马中IGF-1、IGF-2及细胞凋亡的影响
Restor Neurol Neurosci. 2018;36(4):571-581. doi: 10.3233/RNN-170807.
10
Design and in vitro/in vivo Evaluation of Polyelectrolyte Complex Nanoparticles Filled in Enteric-Coated Capsules for Oral Delivery of Insulin.设计并评估了填充在肠溶胶囊中的聚电解质复合物纳米颗粒,用于胰岛素的口服递送。
J Pharm Sci. 2023 Mar;112(3):718-730. doi: 10.1016/j.xphs.2022.09.018. Epub 2022 Sep 21.

引用本文的文献

1
In Vitro and In Vivo Models for Evaluating the Oral Toxicity of Nanomedicines.用于评估纳米药物口服毒性的体外和体内模型
Nanomaterials (Basel). 2020 Oct 31;10(11):2177. doi: 10.3390/nano10112177.
2
Enteric-Coated Strategies in Colorectal Cancer Nanoparticle Drug Delivery System.肠靶向策略在结直肠癌纳米药物传递系统中的应用。
Drug Des Devel Ther. 2020 Oct 21;14:4387-4405. doi: 10.2147/DDDT.S273612. eCollection 2020.